Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 7:26 a.m.	eu	The primary outcome is the upper respiratory tract viral load at Day 5. Method of measurement: Quantitative polymerase chain reaction (PCR) performed on saliva samples at Day 5 of therapy [Time Frame: Day 5 from randomisation]	The primary outcome is the upper respiratory tract viral load at Day 5. Method of measurement: Quantitative polymerase chain reaction (PCR) performed on saliva samples at Day 5 of therapy [Time Frame: Day 5 from randomisation]